๐Ÿ•ต๏ธ Cytosorbents Corp ($CTSO)

SEC insider & ownership activity, last 12 months ยท CIK 1175151 ยท every row links its SEC filing

Over the last 12 months insiders bought $269K with no open-market selling against it. Phillip P. Chan bought $198K (Junโ€“Sep). 3 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Jun 29, 2026.

Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Feb 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$149K Jul 2026: net +$0 Aug 2026: net +$0 Sep 2026: net +$120K
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

4 buyers, $269K (10 lots) ยท 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
Phillip P. Chan4$198K 0โ€“Sep 15, 2026
Peter J. Mariani1$44K 0โ€“Jun 15, 2026
Alan D. Sobel3$15K 0โ€“Sep 15, 2026
Capponi Vincent2$13K 0โ€“Sep 14, 2026

5%+ holders

HolderStakeClassScheduleEvent
Avenir Corp 8.3% 13GFeb 13, 2026 filing โ†—
James H. Rooney 8.3% 13GFeb 13, 2026 filing โ†—
Thomas A. Satterfield, JR. 6.6% 13GJan 17, 2025 filing โ†—
Avenue Capital Management II, L.P. 5.7% 13GMay 28, 2025 filing โ†—
Marc Lasry 5.7% 13GMay 28, 2025 filing โ†—
James H. Rooney 5.7% 13GFeb 14, 2025 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Charter/bylaw changes (5.03)Sep 8, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Sep 8, 2026 filing โ†—
Shareholder vote (5.07)Aug 13, 2026 filing โ†—
Reg FD disclosure (7.01)Aug 6, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 6, 2026 filing โ†—
Earnings (2.02)Aug 6, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 6, 2026 filing โ†—
Delisting notice (3.01)Jun 29, 2026 filing โ†—
Reg FD disclosure (7.01)Jun 24, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 24, 2026 filing โ†—
Earnings (2.02)May 13, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 13, 2026 filing โ†—
Delisting notice (3.01)Apr 1, 2026 filing โ†—
Earnings (2.02)Mar 25, 2026 filing โ†—
Reg FD disclosure (7.01)Mar 25, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 25, 2026 filing โ†—
Earnings (2.02)Nov 13, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 13, 2025 filing โ†—
Delisting notice (3.01)Oct 2, 2025 filing โ†—